Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Life Science Alliance
|
July 25, 2020
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle, Miriam Ruth Heindl, Hannah Limburg, et al.
The Journal of Infectious Diseases
|
December 6, 2007
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories
Marcus Panning, Thomas Laue, Stephan Olschlager, et al.
Journal of Clinical Microbiology
|
July 9, 2010
Analytical performance determination and clinical validation of the novel Roche RealTime Ready Influenza A/H1N1 Detection Set
Jürgen J Wenzel, Marcus Panning, Karen L Kaul, et al.
Journal of Virology
|
September 16, 2004
Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein
Hyun Chul Song, Mi-Young Seo, Konrad Stadler, et al.
The Journal of Infectious Diseases
|
April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
Anindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
The New England Journal of Medicine
|
February 19, 2020
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China
Sebastian Hoehl, Holger Rabenau, Annemarie Berger, et al.
The Journal of Infectious Diseases
|
November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
Joseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
The Lancet. Infectious Diseases
|
August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
Angela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Ebiomedicine
|
April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
Christine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
The Journal of Allergy and Clinical Immunology
|
August 17, 2018
Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses
Daniel P Potaczek, Sebastian D Unger, Nan Zhang, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Life Science Alliance
|
July 25, 2020
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle, Miriam Ruth Heindl, Hannah Limburg, et al.
The Journal of Infectious Diseases
|
December 6, 2007
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories
Marcus Panning, Thomas Laue, Stephan Olschlager, et al.
Journal of Clinical Microbiology
|
July 9, 2010
Analytical performance determination and clinical validation of the novel Roche RealTime Ready Influenza A/H1N1 Detection Set
Jürgen J Wenzel, Marcus Panning, Karen L Kaul, et al.
Journal of Virology
|
September 16, 2004
Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein
Hyun Chul Song, Mi-Young Seo, Konrad Stadler, et al.
The Journal of Infectious Diseases
|
April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
Anindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
The New England Journal of Medicine
|
February 19, 2020
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China
Sebastian Hoehl, Holger Rabenau, Annemarie Berger, et al.
The Journal of Infectious Diseases
|
November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
Joseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
The Lancet. Infectious Diseases
|
August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
Angela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Ebiomedicine
|
April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
Christine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
The Journal of Allergy and Clinical Immunology
|
August 17, 2018
Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses
Daniel P Potaczek, Sebastian D Unger, Nan Zhang, et al.
Page
of 8